The Academy is closely monitoring the spread of COVID-19 across our country, knowing that many of our members and credentialed providers are inevitably on the frontlines of combatting this pandemic while also continuing to take care of current patient loads. Without understanding the full effect COVID-19 may have on people living with HIV, it is imperative to take precaution in caring for this population. To that end, we reached out to our Academy chapter chairs around the country to gather recommendations and special considerations for care and treatment of people with HIV during the COVID-19 pandemic. Click here to view their collective feedback. We hope this is useful information that you might be able to implement to the extent that your state allows.
Interim Guidance for COVID-19 and PWH
Additionally, the following is a summarization of a few key points from DHHS’s first interim guidance for COVID-19 and persons with HIV provided by Academy Chief Medical Officer Dr. Jeffrey T. Kirchner.
Interim Guidance for COVID-19 and Persons with HIV – Updated: March 20, 2020
Current data is limited but do NOT indicate that the disease course of COVID-19 in persons with HIV differs from that in persons without HIV. Before the advent of effective combination ART, advanced HIV infection (CD4 cell count <200/mm3) was a risk factor for complications of other respiratory infections. Whether this is true for COVID-19 is yet unknown.
- Persons aged >60 years (with or without HIV) and those with cardiovascular disease, hypertension, or pulmonary disease are at highest risk of life-threatening COVID-19. Persons with HIV and other comorbidities (e.g., cardiovascular disease or lung disease) are at increased risk for a more severe course of COVID-19 illness. Chronic smokers are also at risk of more severe disease.
- Clinical sites and HIV medical providers should make every effort to help their patients maintain an adequate supply of ART and all other concomitant medications. This includes at least a 30-day supply—and ideally a 90-day supply of medications if possible.
- Persons with HIV and their healthcare providers should weigh the risks and benefits of HIV-related in-person office visit at this time. Factors to consider include the extent of local COVID-19 transmission, health needs that will be addressed during the appointment, the person’s HIV status (e.g., CD4 cell count, HIV viral load) and overall health.
- Telephone or virtual visits for routine or non-urgent care and adherence counseling may replace face-to-face encounters. For persons who have a suppressed HIV viral load and are in stable health, routine medical and laboratory visits should be postponed to the extent possible without negatively affective health and continued control of HIV infection.
Review the full document here.
Additional Resources
As part of the Academy’s continued commitment to provide relevant and useful information during the pandemic, please find additional resources listed below.
Considerations & Suggested Practices for Ambulatory HIV Specialty Care During the COVID-19 Pandemic
Interim Guidance for COVID-19 and Persons with HIV
Therapeutic Options for COVID-19 Patients
CDC: What to Know About HIV and COVID-19
National Pregnancy COVID-19 Registry
HRSA HIV/AIDS Bureau Coronavirus Disease 2019 Update
What You Need to Know About the New Coronavirus and HIV
The COVID-19 Pandemic in the US: A Clinical Update – April 6, 2020
Meeting the Care Needs of Older Adults Isolated at Home During the COVID-19 Pandemic – April 6, 2020
The Promise and Period of Antibody Testing for COVID-19 – April 17, 2020
COVID-19: Special Considerations for People Living with HIV – April 17, 2020
NIH COVID-19 Treatment Guidelines – April 21, 2020
COVID-19 Telehealth Resource Center
Academy Webinar Recording: Tele-PrEP: Preventing HIV in the COVID-19 Pandemic
The Legacy of HIV/AIDS: Lessons for Today
JAMA: Interpreting Diagnostic Tests for SARVS CoV2 – May 2020
Lancet ID Coronavirus Survival Data – May 2020
Clinical Features and Outcomes of HIV Patients with Coronavirus Disease 2019 – May 2020
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy: A Cohort Study – June 2020
SPANISH LANGUAGE RESOURCES:
- Spanish Translation of Interim Guide for COVID-19 and PWH
- Interim Guidance for Implementing Safety Practices for Critical Infrastructure Workers Who May Have Had Exposure to a Person with Suspected or Confirmed COVID-19
- Interim U.S. Guidance for Risk Assessment and Public Health Management of Healthcare Personnel with Potential Exposure in a Healthcare Setting to Patients with Coronavirus Disease 2019
- Essential Workers Dos and Don’ts
The Academy with ANAC co-hosted a webinar on COVID 19: A Clinical Update for HIV Providers. Please find a full recording with corresponding slides from our presenters below. Please note that once you click the above below, the webinar should begin playing automatically on your computer within 3-5 seconds. If not, and it says that there is no content available, please scroll to the bottom of the screen and press the play button.
COVID-19: A Clinical Update for HIV Care Providers
Corresponding slide deck presentations can be accessed here:
- The Impact of COVID-19 on HIV Practice by Jason E. Farley, PhD, MPH, ANP-BC, FAAN, AACRN
- The Impact of COVID-19 on HIV Practice by Cleophas d’Auvergne MD, MPA, (Dip TB WHO/USAID) AAHIVS
If you have additional recommendations, please share your thoughts within our Academy Communities. Given the unprecedented nature of this public health crisis, this should be a time of sharing of best practices in order to combat the pandemic.
